Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients

There is a high clinical unmet need to improve outcomes for pancreatic ductal adenocarcinoma (PDAC) patients, either with the discovery of new therapies or biomarkers that can track response to treatment more efficiently than imaging. We report an innovative approach that will generate renewed inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Freed, Ian M., Kasi, Anup, Fateru, Oluwadamilola, Hu, Mengjia, Gonzalez, Phasin, Weatherington, Nyla, Pathak, Harsh, Hyter, Stephen, Sun, Weijing, Al-Rajabi, Raed, Baranda, Joaquina, Hupert, Mateusz L., Chalise, Prabhakar, Godwin, Andrew K., A. Witek, Malgorzata, Soper, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526802/
https://www.ncbi.nlm.nih.gov/pubmed/37759489
http://dx.doi.org/10.3390/cells12182266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526802/
https://www.ncbi.nlm.nih.gov/pubmed/37759489
http://dx.doi.org/10.3390/cells12182266

Ejemplares similares